Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK.
Saved in:
| Title: | Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK. |
|---|---|
| Authors: | Tsai, Kun-Ling1,2 (AUTHOR), Hsieh, Pei-Ling3 (AUTHOR), Chou, Wan-Ching1 (AUTHOR), Cheng, Hui-Ching1 (AUTHOR), Huang, Yu-Ting1 (AUTHOR), Chan, Shih-Hung4 (AUTHOR) chansh@mail.ncku.edu.tw |
| Source: | Cell & Bioscience. 2/26/2021, Vol. 11 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 20453701 |
|---|---|
| DOI: | 10.1186/s13578-021-00547-y |
